Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer?
Özet
This case report details the unfortunate journey of a 59-year-old breast cancer survivor who developed secondary Retroperitoneal Fibrosis (RPF) in 2022. Despite diligent treatment efforts, her condition took a devastating turn when, in June 2023, she was diagnosed not only with persistent RPF but also with advanced liver, omental, and duodenal cancer. Tragically, her condition deteriorated rapidly, leading to her passing on day 41 following her presentation. This case underscores the challenges of diagnosing and treating RPF. It highlights the importance of considering cancer development in advanced RPF cases that do not respond to treatment, often leaving limited options for effective intervention.
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
Deniz, G., Çakır, M., & Akyagci, S. B. (2024). Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer? JOURNAL OF EMERGENCY MEDICINE CASE REPORTS(1), 12–15. https://doi.org/10.33706/jemcr.1419408
BibTeX
@article{deniz2024-218640,
author = {Deniz, Gulnihal and Çakır, Mürteza and Akyagci, Serpil Bilgin},
title = {Increasing Cases of Retroperitoneal Fibrosis After Covid-19: Case Report, Did She Die Retroperitoneal Fibrosis or Cancer?},
journal = {JOURNAL OF EMERGENCY MEDICINE CASE REPORTS},
year = {2024},
number = {1},
pages = {12--15},
issn = {2149-9934},
doi = {10.33706/jemcr.1419408},
url = {https://akademik.atauni.edu.tr/yayinlar/218640-increasing-cases-of-retroperitoneal-fibrosis-after-covid-19-case-report-did-she}
}